Nanogel-based nasal vaccines for infectious and lifestyle-related diseases

Tatsuhiko Azegami, Yoshikazu Yuki, Rika Nakahashi, Hiroshi Itoh, Hiroshi Kiyono

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Because the mucosa is the major entry route for most pathogens, the development of mucosal vaccines is a rational approach for protecting against these undesired agents. Mucosal administration of vaccine antigen is useful for non-infectious chronic diseases as well, because of its advantages over injection routes, including comparable efficacy in the induction of systemic immune responses, less pain, and no risk of adverse events at the injection site. However, because it is difficult to effectively induce and regulate antigen-specific mucosal and systemic immune responses when antigen alone is mucosally administered, an appropriate form of mucosal delivery vehicle must be used. Antigen delivery systems involving nanogels, which act as artificial chaperones and mucosal adhesives, are a promising approach to overcoming this problem. Here, we introduce current perspectives regarding the development of nanogel-based nasal vaccines for both infectious and lifestyle-related diseases.

Original languageEnglish
JournalMolecular Immunology
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

Nose
Life Style
Vaccines
Antigens
Mucosal Administration
Mucosal Immunity
Injections
Histocompatibility Antigens Class II
Adhesives
Mucous Membrane
Chronic Disease
Pain
NanoGel

Keywords

  • Hypertension
  • Nanogel
  • Nasal vaccine
  • Obesity
  • Pneumonia

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology

Cite this

Nanogel-based nasal vaccines for infectious and lifestyle-related diseases. / Azegami, Tatsuhiko; Yuki, Yoshikazu; Nakahashi, Rika; Itoh, Hiroshi; Kiyono, Hiroshi.

In: Molecular Immunology, 2017.

Research output: Contribution to journalArticle

@article{aeb1ccfb546a426db51e12b249c98022,
title = "Nanogel-based nasal vaccines for infectious and lifestyle-related diseases",
abstract = "Because the mucosa is the major entry route for most pathogens, the development of mucosal vaccines is a rational approach for protecting against these undesired agents. Mucosal administration of vaccine antigen is useful for non-infectious chronic diseases as well, because of its advantages over injection routes, including comparable efficacy in the induction of systemic immune responses, less pain, and no risk of adverse events at the injection site. However, because it is difficult to effectively induce and regulate antigen-specific mucosal and systemic immune responses when antigen alone is mucosally administered, an appropriate form of mucosal delivery vehicle must be used. Antigen delivery systems involving nanogels, which act as artificial chaperones and mucosal adhesives, are a promising approach to overcoming this problem. Here, we introduce current perspectives regarding the development of nanogel-based nasal vaccines for both infectious and lifestyle-related diseases.",
keywords = "Hypertension, Nanogel, Nasal vaccine, Obesity, Pneumonia",
author = "Tatsuhiko Azegami and Yoshikazu Yuki and Rika Nakahashi and Hiroshi Itoh and Hiroshi Kiyono",
year = "2017",
doi = "10.1016/j.molimm.2017.10.022",
language = "English",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Nanogel-based nasal vaccines for infectious and lifestyle-related diseases

AU - Azegami, Tatsuhiko

AU - Yuki, Yoshikazu

AU - Nakahashi, Rika

AU - Itoh, Hiroshi

AU - Kiyono, Hiroshi

PY - 2017

Y1 - 2017

N2 - Because the mucosa is the major entry route for most pathogens, the development of mucosal vaccines is a rational approach for protecting against these undesired agents. Mucosal administration of vaccine antigen is useful for non-infectious chronic diseases as well, because of its advantages over injection routes, including comparable efficacy in the induction of systemic immune responses, less pain, and no risk of adverse events at the injection site. However, because it is difficult to effectively induce and regulate antigen-specific mucosal and systemic immune responses when antigen alone is mucosally administered, an appropriate form of mucosal delivery vehicle must be used. Antigen delivery systems involving nanogels, which act as artificial chaperones and mucosal adhesives, are a promising approach to overcoming this problem. Here, we introduce current perspectives regarding the development of nanogel-based nasal vaccines for both infectious and lifestyle-related diseases.

AB - Because the mucosa is the major entry route for most pathogens, the development of mucosal vaccines is a rational approach for protecting against these undesired agents. Mucosal administration of vaccine antigen is useful for non-infectious chronic diseases as well, because of its advantages over injection routes, including comparable efficacy in the induction of systemic immune responses, less pain, and no risk of adverse events at the injection site. However, because it is difficult to effectively induce and regulate antigen-specific mucosal and systemic immune responses when antigen alone is mucosally administered, an appropriate form of mucosal delivery vehicle must be used. Antigen delivery systems involving nanogels, which act as artificial chaperones and mucosal adhesives, are a promising approach to overcoming this problem. Here, we introduce current perspectives regarding the development of nanogel-based nasal vaccines for both infectious and lifestyle-related diseases.

KW - Hypertension

KW - Nanogel

KW - Nasal vaccine

KW - Obesity

KW - Pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85032722380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032722380&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2017.10.022

DO - 10.1016/j.molimm.2017.10.022

M3 - Article

C2 - 29096936

AN - SCOPUS:85032722380

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

ER -